Orexo AB (ORX) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the conference call. For the first part of the conference call, the participants will be in listen-only mode. During the questions and answer session, participants are able to ask questions by dialing star 5 on their telephone keypad. Now I will hand the conference over to the speakers. Please go ahead. Good afternoon, everyone, and good morning to those of you dialing in from the U.S. I'm Nikolai Sorensen, and I'm here together with Today we're going to go through our fourth quarter and the end result. We will provide a business update. This time it will be a little special because of the transaction we just completed, as most of you are probably aware of, and the divestment of SoftSol. So we will have a lot of focus on the transaction and the implications on the organization and the same for the financials. Financials have a significant impact from this transaction, of course, but also the way that the financials are structured makes it a little more difficult than usual to analyze and understand the implications for the company going forward and even the performance in the last quarter. So Frederick will talk you through that. And then we will end up with a Q&A session. So, very shortly, the quarter in brief. We signed a deal with Dexelfarmer on the 31st of December. We closed the deal on the 31st of December after signing it on the 23rd of December. So, as you can understand, a lot of activities happened over Christmas for many of the employees in the leading positions in Orexo, both in the US and Sweden. This divestment has taken a lot of efforts for the company throughout the autumn and actually even early summer. It has been intense with several companies competing more or less until the last minute for the transaction. So that has caused a lot of w...